Cycloserine microbiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Microbiology[edit | edit source]

Cycloserine inhibits cell–wall synthesis in susceptible strains of Gram positive and Gram negative bacteria and in Mycobacterium tuberculosis.

Susceptibility Tests[edit | edit source]

Cycloserine clinical laboratory standard powder is available for both direct and indirect methods1 of determining the susceptibility of strains of mycobacteria. Cycloserine MICs for susceptible strains are 25 μg/mL or lower.^[1]

References[edit | edit source]

Adapted from the FDA Package Insert.